We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCE icon
1026
BCE
BCE
$20.3B
$4.56M 0.01%
101,801
-126,009
-55% -$5.69M
VHT icon
1027
Vanguard Health Care ETF
VHT
$18.6B
$4.52M 0.01%
18,940
+5,240
+38% +$1.26M
GTACW
1028
CALL
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$4.5M 0.01%
429,791
IBM icon
1029
CALL
IBM
IBM
$215B
$4.48M 0.01%
+34,200
New +$4.58M
PHYT.WS
1030
CALL
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$4.47M 0.01%
425,200
HHLA.WS
1031
CALL
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$4.45M 0.01%
430,336
LH icon
1032
Labcorp
LH
$25.5B
$4.44M 0.01%
22,540
+8,745
+63% +$1.8M
LVAC
1033
DELISTED
LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC
$4.44M 0.01%
425,490
SVNAW
1034
CALL
DELISTED
7 Acquisition Corp Warrant
SVNAW
$4.44M 0.01%
424,999
INVH icon
1035
Invitation Homes
INVH
$17.8B
$4.43M 0.01%
+142,006
New +$4.45M
IHG icon
1036
InterContinental Hotels
IHG
$23.9B
$4.43M 0.01%
66,515
+38,827
+140% +$2.63M
NFNT.WS
1037
CALL
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
$4.42M 0.01%
424,999
RENT
1038
Rent the Runway
RENT
$114M
$4.42M 0.01%
77,587
-20,466
-21% -$1.43M
WPM icon
1039
Wheaton Precious Metals
WPM
$50.2B
$4.42M 0.01%
91,781
-243,649
-73% -$10.7M
JUN.WS
1040
CALL
DELISTED
Juniper II Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
JUN.WS
$4.42M 0.01%
426,300
GRAB icon
1041
Grab
GRAB
$14B
$4.37M 0.01%
1,451,742
+1,363,342
+1,542% +$4.53M
ENTFW
1042
CALL
DELISTED
Enterprise 4.0 Technology Acquisition Corp. Warrant
ENTFW
$4.36M 0.01%
417,378
SLAB icon
1043
Silicon Laboratories
SLAB
$7.18B
$4.35M 0.01%
+24,867
New +$4.18M
TRIS.WS
1044
CALL
DELISTED
Tristar Acquisition I Corp. Redeemable Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRIS.WS
$4.33M 0.01%
419,532
CSTA.WS
1045
CALL
DELISTED
Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CSTA.WS
$4.31M 0.01%
416,663
XMTR icon
1046
Xometry
XMTR
$4.58B
$4.29M 0.01%
286,388
+238,440
+497% +$6.27M
EVE.WS
1047
CALL
DELISTED
EVe Mobility Acquisition Corp Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EVE.WS
$4.27M 0.01%
408,848
VMCAW
1048
CALL
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
$4.26M 0.01%
402,976
WWD icon
1049
Woodward
WWD
$24.5B
$4.26M 0.01%
+43,704
New +$4.4M
RNR icon
1050
RenaissanceRe
RNR
$13.8B
$4.25M 0.01%
+21,231
New +$4.27M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.